The nurse is teaching a patient about treatment with an SSRI antidepressant. Which teaching considerations are appropriate? Select all that apply.

Follow-up after starting antidepressant therapy is essential to evaluate treatment effectiveness and patient safety. One critical concern during early treatment is the risk of suicidal ideation, as some patients may experience increased energy before mood improves, which can heighten the risk of acting on suicidal thoughts. Nurses must assess for any signs of self-harm during follow-up contacts.

C. Suicidal ideation — Antidepressants can increase energy and motivation before mood improves, which may place patients at higher risk for acting on pre-existing suicidal thoughts. Assessing for suicidal ideation is a priority during follow-up.

A. Weakness — While some patients may experience mild fatigue as a side effect, it is not the primary concern in early antidepressant follow-up.

B. Hallucinations — Hallucinations are not a typical adverse effect of standard antidepressant therapy and are not expected in routine follow-up.

D. Difficulty with urination — Urinary retention is uncommon with most antidepressants and is not a primary concern for early treatment monitoring.

Take-Home Points:

• Assess for suicidal thoughts or behaviors, especially within the first few weeks of therapy.
• Educate patients and families to report any sudden mood changes, agitation, or self-harm thoughts immediately.
• Schedule timely follow-ups to monitor treatment effectiveness and safety.

Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for depression and anxiety. While generally safe, SSRIs can interact with other medications and herbal supplements, cause mild adverse effects, and require careful monitoring during initiation or discontinuation. Nurses play a key role in educating patients on safe use, potential interactions, and proper adherence to therapy.

B. Use caution when standing up from a sitting position — SSRIs can cause orthostatic hypotension, especially in older adults or those taking other medications affecting blood pressure. Patients should rise slowly to prevent dizziness or falls.

C. Do not take products containing St. John’s wort — Combining SSRIs with St. John’s wort can increase serotonin levels, raising the risk for serotonin syndrome, a potentially life-threatening condition.

D. Do not stop abruptly — Abrupt discontinuation of SSRIs can lead to withdrawal symptoms, such as dizziness, irritability, nausea, and flu-like symptoms. Gradual tapering under prescriber guidance is essential.

F. Check with the prescriber before taking over-the-counter medications — Many over-the-counter drugs, including decongestants and cold remedies, can interact with SSRIs or exacerbate side effects. Patient education ensures safe concurrent use.

Rationale for incorrect answer:

A. Tyramine-containing foods and 5: dehydration — These are not relevant for SSRIs; tyramine restrictions apply to MAOIs, and dehydration-related toxicity is more relevant for lithium.

Take-Home Points:

• Educate patients about orthostatic precautions and fall prevention.
• Avoid herbal supplements like St. John’s wort to reduce serotonin syndrome risk.
• Emphasize the importance of gradual discontinuation and consulting the prescriber before adding any new medications.